RELATING TO RARE DISEASES.

2025 Regular Session Introduced by Troy Hashimoto

SB 1497 establishes a Rare Disease Advisory Council to improve care, resources, and advocacy for rare disease patients, enhancing their quality of life and healthcare access.

Carried over to 2026 Regular Session.

#doh #establishment #rarediseaseadvisorycouncil #rarediseasepatients

Purpose and Intent

Senate Bill 1497 (SB 1497) aims to address the needs and challenges faced by individuals with rare diseases. The bill seeks to establish a Rare Disease Advisory Council within the Department of Health (DOH) to enhance support, resources, and advocacy for rare disease patients. The intent is to improve the quality of life for these individuals and ensure they receive appropriate care and attention from healthcare systems.

Key Provisions

Establishment of the Rare Disease Advisory Council: The bill proposes the creation of a council that will focus on:

Advising the DOH on policies and programs related to rare diseases.
Identifying gaps in healthcare services for rare disease patients.
Promoting awareness and education about rare diseases among healthcare providers and the public.

Composition of the Council: The council will consist of members with expertise in rare diseases, including healthcare professionals, researchers, and patient advocates. This diverse representation aims to ensure that multiple perspectives are considered in decision-making.

Funding and Resources: While specific funding details are not outlined in the bill, the establishment of the council may lead to the allocation of resources aimed at research, treatment, and support for rare disease patients.

Who Would Be Affected

Rare Disease Patients: Individuals diagnosed with rare diseases will benefit directly from the council's initiatives, which are designed to improve access to care and resources.

Healthcare Providers: The bill will impact healthcare professionals by enhancing their understanding of rare diseases through education and training initiatives.

Researchers and Advocates: Those involved in research and advocacy for rare diseases will have a platform to voice their concerns and recommendations, potentially leading to increased funding and support for research initiatives.

Procedural Aspects

Legislative Timeline:

Introduced: January 22, 2025
First Reading: January 23, 2025 (passed)
Referred to Committees: January 27, 2025 (Health and Human Services (HHS) and Ways and Means (WAM))

Related Legislation: SB 1497 has a companion bill, HB 1288, which may provide additional context or support for similar initiatives in the House.

Conclusion

SB 1497 represents a significant step towards improving the lives of individuals affected by rare diseases. By establishing a dedicated advisory council, the bill aims to foster collaboration among stakeholders, enhance awareness, and ultimately improve healthcare outcomes for this vulnerable population. The ongoing legislative process will determine the final structure and funding of the council, as well as its potential impact on rare disease advocacy and care.

Bill